166.62MMarket Cap
LossP/E TTM
Pyxis Oncology Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Pyxis Oncology Inc is 6.58, ranking 320 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.02, which is -81.32% below the recent high of -0.38 and -121.47% above the recent low of -4.48.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.